サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1785913

犬関節炎治療の世界市場

Canine Arthritis Treatment

出版日
ページ情報
英文 214 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
犬関節炎治療の世界市場
出版日: 2025年08月07日
発行: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
ページ情報: 英文 214 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

犬関節炎治療の世界市場は2030年までに30億米ドルに到達

2024年に24億米ドルと推定される犬関節炎治療の世界市場は、2024～2030年の分析期間においてCAGR 3.5%で成長し、2030年には30億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである医薬品治療は、CAGR 4.1%を記録し、分析期間終了時には14億米ドルに達すると予測されます。サプリメント治療分野の成長率は、分析期間中CAGR 3.4％と推定されます。

米国市場は6億6,100万米ドルと推定、中国はCAGR6.7％で成長予測

米国の犬関節炎治療市場は、2024年に6億6,100万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.7%として、2030年までに6億40万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.7%と予測されています。欧州では、ドイツがCAGR 2.0%で成長すると予測されています。

世界の犬関節炎治療市場- 主要動向と促進要因まとめ

なぜ犬の関節炎はペットオーナーの間で関心が高まっているのか？

犬の関節炎は、特に獣医学的ケアの進歩が犬の長寿命化につながるにつれて、大きな健康上の懸念となっています。この退行性関節疾患は、痛み、可動性の低下、および生活の質の低下を引き起こし、世界的に何百万ものペットに影響を与えます。関節の健康に対する飼い主の意識の高まりは、ペットの人間化の動向と相まって、関節炎治療市場を大幅に拡大させています。獣医師は現在、予後を改善するために早期診断と複数の治療アプローチに重点を置いており、医薬品と非医薬品の両方のソリューションに対する需要を牽引しています。さらに、犬の肥満の有病率の増加は、関節炎の症例を悪化させ、効果的な治療オプションの必要性をさらに煽っています。

獣医療における技術革新はどのように関節炎管理を改善しているのか？

犬関節炎治療市場は、近年大きな進歩を遂げており、新しい治療法が痛みの緩和や関節のサポートを改善しています。幹細胞治療や多血小板血漿（PRP）治療を含む再生医療は、損傷した軟骨を修復し、疾患の進行を遅らせる可能性があるとして支持を集めています。疼痛経路を標的とするモノクローナル抗体などの生物学的製剤の進歩も関節炎管理に革命をもたらし、より少ない副作用でより長期の緩和を提供しています。さらに、オメガ3脂肪酸やグルコサミンのサプリメントを含む栄養補助食品の開発は、非侵襲的な治療の選択肢を広げています。整形外科用装具や水処理器における技術革新は、老犬のための全人的関節炎ケアをさらにサポートしています。

どの市場セグメンテーションが犬の関節炎治療の需要を牽引しているか？

犬の関節炎治療に対する需要は、ペット用医薬品、動物病院、ペット保険業者、オンラインペット健康小売業者など、複数のセグメントにわたって成長しています。非ステロイド性抗炎症薬（NSAIDs）、鎮痛薬（An analgesics）、再生薬（Regenerative medicines）を含む医薬品セグメントは、依然として市場収益への最大の貢献者です。動物病院では、理学療法や生活習慣の改善を取り入れた関節炎管理プログラムを提供するところが増えています。ペット保険会社は、高度な関節炎治療をカバーすることで、市場の成長に重要な役割を果たしており、ペットの飼い主がよりアクセスしやすくなっています。さらに、消費者直販のペット健康ブランドは、eコマース・チャネルを通じて関節サプリメントや療法食の利用可能性を拡大しています。

犬関節炎治療市場の成長を促進する要因とは？

犬関節炎治療市場の成長は、ペットの長寿化、関節の健康に対する意識の高まり、獣医学的治療法の進歩など、いくつかの要因によって牽引されています。ペットの予防医療や早期介入戦略へのシフトは、診断ツールや長期関節炎管理プランの需要を押し上げています。拡大するペット保険業界はまた、高度な関節炎治療をより手頃な価格にして、高価な治療オプションへのより大きなアクセスを容易にしました。さらに、オンライン動物薬局や遠隔医療サービスの台頭は、ペットの所有者が複数の治療の選択肢を検討することができ、関節炎治療へのアクセシビリティを向上させました。ペットの飼い主が老犬の生活の質を優先し続けるにつれて、革新的で効果的な関節炎治療に対する需要は増加すると予想されます。

セグメント

治療タイプ（薬物治療、サプリメント治療、外科的処置、その他の治療タイプ）、関節炎タイプ（変形性関節症治療、骨軟骨症治療、関節リウマチ治療、外傷性関節炎治療）

調査対象企業の例

  • Adequan Canine（American Regent Animal Health）
  • American Regent, Inc.
  • Boehringer Ingelheim Animal Health
  • Cartrophen Vet（Arthropharm）
  • Cosequin（Nutramax Laboratories）
  • Dasuquin（Nutramax Laboratories）
  • Elanco Animal Health
  • Liquid Health, Inc.
  • Matsun Nutrition
  • Nutramax Laboratories Veterinary Sciences, Inc.
  • Nutri-Vet, LLC
  • Parnell Pharmaceuticals Holdings Ltd.
  • Pet Tech Labs
  • Synflex America Inc.
  • Thorne Research Inc.
  • Vetalogica
  • VetIQ
  • Wuffes
  • YuMOVE（Lintbells）
  • Zoetis Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29773

Global Canine Arthritis Treatment Market to Reach US$3.0 Billion by 2030

The global market for Canine Arthritis Treatment estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Drugs Treatment, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Supplements Treatment segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$661.0 Million While China is Forecast to Grow at 6.7% CAGR

The Canine Arthritis Treatment market in the U.S. is estimated at US$661.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$600.4 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Canine Arthritis Treatment Market - Key Trends & Drivers Summarized

Why Is Canine Arthritis a Growing Concern Among Pet Owners?

Canine arthritis has become a major health concern, particularly as advances in veterinary care lead to longer lifespans for dogs. This degenerative joint disease affects millions of pets globally, causing pain, reduced mobility, and a decline in quality of life. The increasing awareness among pet owners about joint health, combined with the rise in pet humanization trends, has significantly expanded the market for arthritis treatments. Veterinarians are now focusing on early diagnosis and multimodal treatment approaches to improve outcomes, driving demand for both pharmaceutical and non-pharmaceutical solutions. Additionally, the growing prevalence of obesity in dogs has exacerbated arthritis cases, further fueling the need for effective treatment options.

How Are Innovations in Veterinary Medicine Improving Arthritis Management?

The canine arthritis treatment market has seen significant advancements in recent years, with novel therapies offering improved pain relief and joint support. Regenerative medicine, including stem cell therapy and platelet-rich plasma (PRP) treatments, is gaining traction for its potential to repair damaged cartilage and slow disease progression. Advances in biologic drugs, such as monoclonal antibodies targeting pain pathways, have also revolutionized arthritis management, providing longer-lasting relief with fewer side effects. Additionally, the development of nutraceuticals, including omega-3 fatty acids and glucosamine supplements, has expanded non-invasive treatment options. Technological innovations in orthopedic braces and hydrotherapy equipment further support holistic arthritis care for aging dogs.

Which Market Segments Are Driving Demand for Canine Arthritis Treatments?

The demand for canine arthritis treatments is growing across multiple segments, including pet pharmaceuticals, veterinary clinics, pet insurance providers, and online pet health retailers. The pharmaceutical segment, encompassing NSAIDs, analgesics, and regenerative medicines, remains the largest contributor to market revenue. Veterinary clinics are increasingly offering specialized arthritis management programs, incorporating physiotherapy and lifestyle modifications. Pet insurance companies are playing a key role in market growth by covering advanced arthritis treatments, making them more accessible to pet owners. Additionally, direct-to-consumer pet health brands are expanding the availability of joint supplements and therapeutic diets through e-commerce channels.

What Factors Are Driving the Growth of the Canine Arthritis Treatment Market?

The growth in the canine arthritis treatment market is driven by several factors, including increasing pet longevity, rising awareness of joint health, and advancements in veterinary therapeutics. The shift toward preventive pet care and early intervention strategies has boosted demand for diagnostic tools and long-term arthritis management plans. The expanding pet insurance industry has also facilitated greater access to expensive treatment options, making advanced arthritis therapies more affordable. Additionally, the rise of online veterinary pharmacies and telemedicine services has improved accessibility to arthritis treatments, allowing pet owners to explore multiple care options. As pet owners continue to prioritize quality of life for their aging dogs, the demand for innovative and effective arthritis treatments is expected to rise.

SCOPE OF STUDY:

The report analyzes the Canine Arthritis Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Drugs Treatment, Supplements Treatment, Surgical Procedures, Other Treatment Types); Arthritis Type (Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment, Traumatic Arthritis Treatment)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Adequan Canine (American Regent Animal Health)
  • American Regent, Inc.
  • Boehringer Ingelheim Animal Health
  • Cartrophen Vet (Arthropharm)
  • Cosequin (Nutramax Laboratories)
  • Dasuquin (Nutramax Laboratories)
  • Elanco Animal Health
  • Liquid Health, Inc.
  • Matsun Nutrition
  • Nutramax Laboratories Veterinary Sciences, Inc.
  • Nutri-Vet, LLC
  • Parnell Pharmaceuticals Holdings Ltd.
  • Pet Tech Labs
  • Synflex America Inc.
  • Thorne Research Inc.
  • Vetalogica
  • VetIQ
  • Wuffes
  • YuMOVE (Lintbells)
  • Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Canine Arthritis Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Aging Pet Population Driving Demand for Arthritis Treatment Products
    • Rising Humanization of Pets Fueling Investment in Premium Care Solutions
    • Advancements in Veterinary Diagnostics Increasing Early Arthritis Detection
    • Growth in Natural and Alternative Therapy Solutions Attracting Wellness-Focused Pet Owners
    • Increased Awareness of Pain Management Solutions Through Digital Platforms
    • Expansion of Tele-Veterinary Services Improving Access to Treatment Options
    • Integration of Joint Supplements Into Regular Pet Care Routines
    • Surge in Demand for Non-Invasive Pain Relief Technologies for Pets
    • Growing Adoption of Nutraceuticals and CBD-Based Arthritis Products
    • Development of Breed-Specific and Weight-Specific Treatment Plans Improving Outcomes
    • Innovation in Long-Acting Injectable Therapies Driving Compliance and Ease of Use
    • Emergence of Wearable Pet Health Trackers Aiding Continuous Mobility Monitoring
    • Expanding Pet Insurance Coverage Increasing Affordability of Treatments
    • Strategic Partnerships Between Pet Clinics and Pharmaceutical Companies
    • Increased Consumer Education Around Early Signs and Prevention Boosting Proactive Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Canine Arthritis Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Drugs Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Drugs Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Supplements Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Supplements Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Surgical Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Surgical Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Osteoarthritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Osteoarthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Osteochondrosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Osteochondrosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Rheumatoid Arthritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Rheumatoid Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Traumatic Arthritis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Traumatic Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • JAPAN
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • CHINA
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • EUROPE
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • FRANCE
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: France 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • GERMANY
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Germany 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Italy 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • UNITED KINGDOM
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: UK 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • SPAIN
    • TABLE 58: Spain Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Spain 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 60: Spain Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Spain 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • RUSSIA
    • TABLE 62: Russia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Russia 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 64: Russia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Russia 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 66: Rest of Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of Europe 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 68: Rest of Europe Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Europe 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 70: Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 71: Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 72: Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • AUSTRALIA
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 76: Australia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Australia 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 78: Australia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Australia 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • INDIA
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 80: India Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: India 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 82: India Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: India 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 84: South Korea Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: South Korea 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 86: South Korea Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: South Korea 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 88: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 90: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Asia-Pacific 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • LATIN AMERICA
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 92: Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Latin America 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 94: Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Latin America 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 96: Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Latin America 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 98: Argentina Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Argentina 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 100: Argentina Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Argentina 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • BRAZIL
    • TABLE 102: Brazil Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Brazil 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 104: Brazil Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Brazil 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • MEXICO
    • TABLE 106: Mexico Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Mexico 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 108: Mexico Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Mexico 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 110: Rest of Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Latin America 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 112: Rest of Latin America Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Latin America 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • MIDDLE EAST
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 114: Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 115: Middle East 6-Year Perspective for Canine Arthritis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 116: Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Middle East 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 118: Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Middle East 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • IRAN
    • TABLE 120: Iran Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Iran 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 122: Iran Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Iran 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • ISRAEL
    • TABLE 124: Israel Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Israel 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 126: Israel Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Israel 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 128: Saudi Arabia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Saudi Arabia 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 130: Saudi Arabia Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Saudi Arabia 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 132: UAE Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: UAE 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 134: UAE Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UAE 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 136: Rest of Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Rest of Middle East 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 138: Rest of Middle East Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Rest of Middle East 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030
  • AFRICA
    • Canine Arthritis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 140: Africa Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Treatment Type - Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Africa 6-Year Perspective for Canine Arthritis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Drugs Treatment, Supplements Treatment, Surgical Procedures and Other Treatment Types for the Years 2025 & 2030
    • TABLE 142: Africa Recent Past, Current & Future Analysis for Canine Arthritis Treatment by Arthritis Type - Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Africa 6-Year Perspective for Canine Arthritis Treatment by Arthritis Type - Percentage Breakdown of Value Sales for Osteoarthritis Treatment, Osteochondrosis Treatment, Rheumatoid Arthritis Treatment and Traumatic Arthritis Treatment for the Years 2025 & 2030

IV. COMPETITION